# Tachosil for the Prevention of Symptomatic Lymph Cysts

> **NCT01470677** · PHASE3 · COMPLETED · sponsor: **Ruhr University of Bochum** · enrollment: 220 (actual)

## Conditions studied

- Endometrial Cancer
- Cervical Cancer

## Interventions

- **DRUG:** Tachosil fibrin patch

## Key facts

- **NCT ID:** NCT01470677
- **Lead sponsor:** Ruhr University of Bochum
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-11
- **Primary completion:** 2016-01
- **Final completion:** 2016-01
- **Target enrollment:** 220 (ACTUAL)
- **Last updated:** 2022-07-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01470677

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01470677, "Tachosil for the Prevention of Symptomatic Lymph Cysts". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01470677. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*